Regenerative Medicine Market to Grow at 20.7% CAGR Driven by Cell Therapy Products to 2020

India - English

News provided by

Jun 01, 2016, 04:00 ET

PUNE, India, June 1, 2016 /PRNewswire/ --

One trend that will positively impact the regenerative medicine market is the high number of regenerative medicines in the pipeline as the industry may witness development and launch of many new therapies during the forecast period. There are many regenerative medicine pipeline products that are in different stages of development, ranging from discovery, pre-clinical phase to mid-stage and late-stage phase. As per the estimation in 2015, more than 2,500 regenerative medicines were under clinical trials.

Complete report on regenerative medicine market spread across 117 pages, analyzing 6 major companies and providing 67 data exhibits is now available at http://www.rnrmarketresearch.com/global-regenerative-medicine-market-2016-2020-market-report.html .

The analysts forecast global regenerative medicine market to grow at a CAGR of 20.7% during the period 2016-2020. According to the 2016 report, a key growth driver for regenerative medicine market is the increased focus on cell therapy products. There are more than 40 approved cell therapy products in the market. Most small and large biotech companies are working on various cell types such as progenitor cells, adult and embryonic stem cells, and iPSCs. These cells have proved their efficacy in the treatment of chronic heart failure, cancer, and diabetes. Most of the cell therapy products are marketed for wound and dermal graft; however, there are only few products for cancer.

The regenerative medicine market in the Americas was valued at USD 1.93 billion in 2015. The market in the Americas is expected to grow at a rapid pace during the forecast period because of increased demand for tissue-engineered and stem cell products for the treatment of various diseases. Rise in the NIH and BARDA funding in the US, and development of regenerative medicines in Canada and the US will also boost the market. The regenerative medicine markets in EMEA were valued at USD 1.27 billion in 2015. It is estimated that around 30% of the population is suffering from chronic disorders such as diabetes, liver diseases, and blood disorders. Hence, the UK government is helping institutes and vendors fund their research in regenerative medicines.

The following companies are the key players in the global regenerative medicine market: Acelity, Medtronic, MiMedx Group, Organogenesis, UniQure, and ZimmerBiomet. Other Prominent Vendors in the market are: ACE Surgical Supply, Acologix, Advanced Biologics, AlloCure, Allosource, Alphatec Spine, Altrika, Amorcyte, Anterogen, Antibe Therapeutics, Astellas Pharma, Athersys, Avita Medical, AxoGen, Bacterin International, Baxter, Bellicum Pharmaceuticals, BioCardia and more.

Most cell-based immunotherapy trials are conducted in the US and European countries. The scope of cell therapy products is widening with around 300 companies and many institutes conducting more than 1,900 clinical trials around the world. Regulatory approval of products is likely to further boost its demand and augment market growth during the forecast period. Order a copy of Global Regenerative Medicine Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=582848 .

Further, the regenerative medicine market report states that one challenge that could hamper market growth is the high cost and failure rate in clinical trials.

Another related report is Global Orthobiologics Market 2016-2020; the analysts forecast global orthobiologics market to grow at a CAGR of 7.03% during the period 2016-2020. A major trend that is expected to boost the market growth during the forecast period is the increase in funds to enhance orthobiologics. Vendors in the market are extensively investing in research to develop a wide range of innovative products, strengthening their portfolio and successful commercialization of products. Browse complete report @ http://www.rnrmarketresearch.com/global-orthobiologics-market-2016-2020-market-report.html.

Explore other new reports on Tissue Engineering Market @ http://www.rnrmarketresearch.com/reports/life-sciences/biotechnology/tissue-engineering.

About Us:

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel: +1-888-391-5441
[email protected]

Connect with Us:

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

SOURCE RnR Market Research